2025-08-08 20:44:11
Latest Post
Zydus receives final approval from USFDA for Prucalopride Tablets, 1 mg and 2 mg
Central Bank of India Launches Pioneering TReDS Insurance Policy In Strategic Partnership With TATA AIG
Bangur Concrete Launches First RMC Plant in Karnataka, Enters South India Market
Gateway Distriparks Signs Exclusive Container Train Operations Agreement for MMLP, Ankleshwar
RBI grants NBFC license to Equirus Group
Stock Report
Superhouse Ltd posts rise in Q3FY23 consolidated PAT to Rs. 10.21 crores
Posted On : 2023-02-12 21:46:47( TIMEZONE : IST )
Superhouse Limited has reported Consolidated financial results for the period ended December 31, 2022.
Financial Results (Q3 FY2023) - QoQ Comparison
The company has reported total income of Rs. 196.6131 crores during the period ended December 31, 2022 as compared to Rs. 224.1280 crores during the period ended September 30, 2022.
The company has posted net profit / (loss) of Rs. 10.2144 crores for the period ended December 31, 2022 as against net profit / (loss) of Rs. 6.4870 crores for the period ended September 30, 2022.
The company has reported EPS of Rs. 9.26 for the period ended December 31, 2022 as compared to Rs. 5.88 for the period ended September 30, 2022.
| Financials | Q3 FY2023 | Q2 FY2023 | % Change |
| Total Income | ₹196.6131 crs | ₹224.1280 crs |  -12.28% |
| Net Profit | ₹10.2144 crs | ₹6.4870 crs |  57.46% |
| EPS | ₹9.26 | ₹5.88 | 57.48% |
Financial Results (Q3 FY2023) - YoY Comparison
The company has reported total income of Rs.196.6131 crores during the period ended December 31, 2022 as compared to Rs.157.7251 crores during the period ended December 31, 2021.
The company has posted net profit / (loss) of Rs.10.2144 crores for the period ended December 31, 2022 as against net profit / (loss) of Rs.7.5667 crores for the period ended December 31, 2021.
The company has reported EPS of Rs.9.26 for the period ended December 31, 2022 as compared to Rs.6.86 for the period ended December 31, 2021.
| Financials | Q3 FY2023 | Q3 FY2022 | % Change |
| Total Income | ₹196.6131 crs | ₹157.7251 crs | 24.66% |
| Net Profit | ₹10.2144 crs | ₹7.5667 crs | 34.99% |
| EPS | ₹9.26 | ₹6.86 | 34.99% |
Financial Results (9 Months Ended FY2023) - YoY Comparison
The company has reported total income of Rs.600.5352 crores during the 9 Months period ended December 31, 2022 as compared to Rs.468.9667 crores during the 9 Months period ended December 31, 2021.
The company has posted net profit / (loss) of Rs.22.7074 crores for the 9 Months period ended December 31, 2022 as against net profit / (loss) of Rs.23.3235 crores for the 9 Months period ended December 31, 2021.
The company has reported EPS of Rs.20.60 for the 9 Months period ended December 31, 2022 as compared to Rs.21.16 for the 9 Months period ended December 31, 2021.
| Financials | 9 Months Ended FY2023 | 9 Months Ended FY2022 | % Change |
| Total Income | ₹600.5352 crs | ₹468.9667 crs | 28.05% |
| Net Profit | ₹22.7074 crs | ₹23.3235 crs | -2.64% |
| EPS | ₹20.60 | ₹21.16 | -2.65% |
Shares of Superhouse Limited was last trading in BSE at Rs. 204.05 as compared to the previous close of Rs. 204.60. The total number of shares traded during the day was 1534 in over 136 trades.
The stock hit an intraday high of Rs. 210.00 and intraday low of 200.05. The net turnover during the day was Rs. 316731.00.
